Insider Transactions in Q2 2025 at Data Knights Acquisition Corp. (DKDCW)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2025
|
Thomas Kosasa Director |
BUY
Open market or private purchase
|
Direct |
1,190,476
+7.28%
|
$0
$0.42 P/Share
|
|
Jun 20
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,666,666
+19.83%
|
$0
$0.42 P/Share
|
|
Jun 19
2025
|
Thomas Kosasa Director |
BUY
Conversion of derivative security
|
Direct |
4,988,440
+16.54%
|
$0
$0.73 P/Share
|
|
Jun 19
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Conversion of derivative security
|
Direct |
1,828,279
+26.5%
|
$0
$0.71 P/Share
|
|
Jun 17
2025
|
Thomas Kosasa Director |
BUY
Conversion of derivative security
|
Direct |
493,056
+5.21%
|
$493,056
$1.14 P/Share
|
|
Jun 17
2025
|
Aaron Green Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
240,425
+21.36%
|
$240,425
$1.14 P/Share
|
|
Jun 17
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Conversion of derivative security
|
Direct |
479,270
+12.88%
|
$479,270
$1.14 P/Share
|
|
Jun 16
2025
|
Thomas Kosasa Director |
BUY
Open market or private purchase
|
Direct |
55,000
+0.64%
|
$0
$0.38 P/Share
|
|
Apr 21
2025
|
Thomas Kosasa Director |
BUY
Open market or private purchase
|
Direct |
47,000
+0.55%
|
$0
$0.49 P/Share
|